Effect of peri-operative infusion of dexmedetomidine in pre-eclamptic pregnant women undergoing elective caesarian Section under general anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202412834702557

Enrollment

Registered

2024-12-10

Start date

2021-11-06

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Perioperative infusion of saline

Perioperative infusion of dexmedetomidine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women with an ASA physical status classification of II or III, diagnosed with mild preeclampsia, and planned for an elective cesarean section with general anesthesia.

Exclusion criteria

Exclusion criteria: age below 21 or above 40 years, with an ASA physical status below III, with pre-existing neurological, cardiac, respiratory, renal, or liver conditions, moderate to severe preeclampsia

Design outcomes

Primary

Measure	Time frame
assess heart rate (beats/min), systolic blood pressure (mmHg), and diastolic blood pressure (mmHg) measurements of the studied groups	—

Secondary

Measure	Time frame
assess the heart rate (beats/min), systolic blood pressure (mmHg), and diastolic blood pressure postoperatively in addition to measurement of VAS, sedation levels, APGAR score, total pethidine dose consumption, time to first analgesic request, and adverse events as hypotension, and bradycardia of the studied groups.	—

Countries

Egypt

Contacts

Public ContactMedhat Helaly Allam

Professor

medhathelaly@gmail.com+21003012989

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026